The patient
A 69-year-old postmenopausal woman consulted for frontal hair loss for two years. She had started menopause at the age of 50 years old and had been taking bisphosphonates for her osteoporosis for two years. Her clinical history, including gynecological data, was otherwise negative. Anamnestic data ruled out the possibility of traction alopecia. Dermatological examination revealed a Fitzpatrick skin type III. She had a linear frontotemporal recession with perifollicular erythema, lonely hairs on the frontal region, and scarring alopecia (Figure 1) . The patient had a total loss of eyebrows but she did not have body hair loss. There were no other skin or mucosal abnormalities. Thyroid hormone function was also normal.
Dermoscopy with a non-contact polarizing FotoFinder dermatoscope x20 (FotoFinder Systems, Inc, Bad Birnbach, 
What is your diagnosis? Diagnosis
Frontal fibrosing alopecia
Clinical course
The patient was treated with minoxidil 2% with a slight improvement of her scarring alopecia.
Discussion
Frontal fibrosing alopecia (FFA) is a relatively recently recognized condition of unknown origin and was first described in 1994 [1] . It is generally considered as a variant of lichen planopilaris primarily affecting postmenopausal women. between traction alopecia, alopecia areata and cicatricial marginal alopecia. In fact, our patient had a cicatricial alopecia with the absence of yellow dots and dystrophic hairs, which are the most relevant dermoscopic findings in alopecia areata.
Anamnestic data ruled out the possibility of traction alopecia characterized by the absence of miniaturized hairs, white dots and fractured hair shafts at dermoscopic examination [7] [8] [9] .
As for cicatricial marginal alopecia (CMA), this entity is characterized by an area of permanent hair loss that involves mainly the crown and vertex and spreads centrifugally. CMA is characterized dermoscopically by low hair density, loss of follicular ostia with a peripilar white gray halo around the emergence of hairs that were absent in our patient [10, 11] .
Currently, no treatment protocols exist for FFA. Stabilization of hair loss is occasionally observed with various topical or systemic therapies such as oral 5-α-reductase inhibitors, hydroxychloroquine, minoxidil and topical or intralesional corticosteroids. The aim of the treatment is to arrest hair loss.
Improvement of FFA was most often seen when treated with oral finasteride or dutasteride, but a spontaneous stabilization of the disease may also occur. The regrowth of hair is usually minimal and always located at the hairline [12] . Some treatments may reduce inflammation, but the impact on progression of alopecia is uncertain.
We report this case not only for the rarity of the disease but also to underline the role of dermoscopy as a very useful tool in the diagnosis of frontal fibrosing alopecia. In fact, the characteristic clinical presentation together with typical dermoscopic features could help in avoiding unnecessary biopsies in patients with frontal fibrosing alopecia. Hence,
